# BASF India share price today (BASF India Ltd, NSE: BASF)

> BASF India share price today: ₹2,958.60 at the NSE close on 4 November 2026, down 33.5% in a year. BASF India (NSE: BASF) is worth ₹12,807 crore, trades at a P/E of 20.8 and has closed between ₹2,958.60 and ₹4,448.60 over the past 52 weeks. > BASF India Ltd's share price has fallen more than its earnings. Earnings per share fell 12.3% in a year while the price moved −33.5%. BASF · Chemicals - Organic · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/basf-india-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: ₹2,958.60 (−33.5% in a year)
- P/E: 20.8× (lower than 100% of the last 6 years)
- Revenue (Jun 2026): ₹4,824 Cr (+24.5% on a year ago)
- Profit (Jun 2026): ₹360 Cr (+162.8% on a year ago)
- Operating margin: 10.0% (+4.0 points on a year ago)
- ROCE: 15%, FY26
- ROIC: 16.1%, against a 12.0% cost of capital: +4.1 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the BASF India share price today? BASF India Ltd's share price was ₹2,958.60 at the close on 4 November 2026. It has been falling for 64 weeks. That is 20.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹2,959 and ₹4,449, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 5 weeks running. Over the last 11 years the share price moved +282% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 1 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at BASF India this quarter? Three changes stood out: best operating margin in 11 quarters, highest quarterly profit in 12 quarters and highest quarterly revenue in 15 quarters. 1. Best operating margin in 11 quarters Operating margin was 10% in the June 2026 quarter, against 6% a year earlier. 2. Highest quarterly profit in 12 quarters Profit of ₹360 crore in the June 2026 quarter is the highest of the last 12 quarters. 3. Highest quarterly revenue in 15 quarters Revenue of ₹4,824 crore in the June 2026 quarter is the highest of the last 15 quarters. ## What are BASF India's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), BASF India reported revenue of ₹4,824 crore, up 24.5% from ₹3,875 crore a year earlier, and a profit of ₹360 crore, up 162.8% from ₹137 crore. ### BASF India results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹4,824 crore | ₹3,875 crore | +24.5% |
| Profit | ₹360 crore | ₹137 crore | +162.8% |
| Earnings per share | ₹83.24 | ₹31.74 | +162.3% |
| Operating margin | 10.0% | 6.0% | +4.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the BASF India share price history? BASF India closed at ₹2,958.60 on 4 November 2026, down 33.5% from ₹4,448.60 a year earlier (7 November 2025) and down 8.4% over five years. Its highest weekly close since March 2016 was ₹8,310.30 on 1 November 2024. ### BASF India share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹3,049.10 | −3.0% |
| 1 month ago · 1 Oct 2026 | ₹3,417.10 | −13.4% |
| 6 months ago · 8 May 2026 | ₹4,029.80 | −26.6% |
| 1 year ago · 7 Nov 2025 | ₹4,448.60 | −33.5% |
| 3 years ago · 3 Nov 2023 | ₹2,549.70 | +16.0% |
| 5 years ago · 4 Nov 2021 | ₹3,229.60 | −8.4% |
| 10 years ago · 4 Nov 2016 | ₹1,223.40 | +141.8% |
| Earliest and lowest weekly close in our records · 11 Mar 2016 | ₹774.65 | +281.9% |
| Highest weekly close since March 2016 · 1 Nov 2024 | ₹8,310.30 | −64.4% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹4,448.60 | −33.5% |
| 52-week low (weekly close) · 4 Nov 2026 | ₹2,958.60 | 0.0% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (563 weekly closes from 11 March 2016 to 4 November 2026.)

## What is the latest news on BASF India? 4 Nov 2026: BASF India closed at ₹2,958.60, down 3.0% on the week and down 13.4% on the month. 30 Jul 2026: ex-date for a dividend of ₹25 a share. ### Earlier

- Results for April to June 2026: Revenue up 24.5% and profit up 162.8% on a year earlier. ## What dividend does BASF India pay? BASF India paid ₹25 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.84% at the ₹2,958.60 close on 4 November 2026. The last was a dividend of ₹25 a share, ex-date 30 July 2026. ### BASF India dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 30 Jul 2026 | ₹25 | Dividend |
| 30 Jul 2025 | ₹20 | Dividend |
| 26 Jul 2024 | ₹15 | Dividend |
| 21 Jul 2023 | ₹8 | Dividend |
| 21 Jul 2022 | ₹6 | Dividend |
| 22 Jul 2021 | ₹10 | Dividend + Special |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. BASF India Ltd paid out 26% of its profit as dividends in FY26, and it paid a dividend in each of its last 9 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## Which stock lists is BASF India on? BASF India is on 2 of our India lists: 52 week high & low and Small & mid cap stocks. - [52 week high & low 52-week position: Near 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)
- [Small & mid cap stocks Size rank in India: 479](https://www.sectoralpha.in/small-cap-stocks-india)

## Is BASF India profitable? BASF India Ltd earned ₹360 Cr of net profit in the Jun 2026 quarter, +162.8% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹420 Cr. Over 20 years profit has grown 11.8% a year on average. That is 7.5% of the quarter's revenue. The same quarter a year earlier earned ₹137 Cr. For the full year, FY26 profit was ₹420 Cr (−12.3% on the year before). Why profit moved: revenue changed +24.5% on a year earlier and the margin moved +4.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +76.2% and revenue +6.8%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does BASF India make, and is it growing? BASF India Ltd reported ₹4,824 Cr of revenue in the Jun 2026 quarter, +24.5% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 20 years it has grown 16.7% a year on average. The last full year, FY26, came in at ₹14,944 Cr. The last four reported quarters add to ₹16,027 Cr. FY26 revenue was ₹14,944 Cr, +1.1% on the year before. Recent pace: the last four quarters grew +6.8% on average, against 16.7% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +6.5%, against +10.4% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +62.4%, against +0.5% a year (accelerating). ## How much of every ₹100 of sales does BASF India keep? BASF India Ltd's operating margin was 10.0% in the Jun 2026 quarter, 4.0 percentage points higher than the same quarter a year ago. Across 9 years it has been between 3.7% and 13.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +4.9 percentage points on the year while gross margin changed +2.6 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is BASF India's profit turning into cash? Over the last 3 years, 73% of BASF India Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 its operations used ₹110 Cr of cash, against ₹420 Cr of profit. After ₹156 Cr of spending on assets, free cash was −₹266 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 73% of profit came in as cash: the cash cycle got 20 days shorter between FY08 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does BASF India's cash go? BASF India Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 40 days in FY26, down from 60 days in FY08. It spent ₹513 Cr on assets over the last 3 years. Customers take 67 days to pay, and stock sits for 77 days on average. At FY26 sales of ₹14,944 Cr, each day of that cycle ties up about ₹40.9 Cr, so roughly ₹1,638 Cr is tied up in the business at any time. FY26: customers took 67 days to pay and stock sat for 77 days, about 2.5 months of sales sitting as stock, for a full cycle of 40 days, shorter than FY08's 60. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 77 days. Customers pay about 67 days after that. Suppliers are paid at 104 days. Together that makes the 40-day cycle. Spending on assets: ₹513 Cr over the last 3 years, against ₹343 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹160 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is BASF India's P/E ratio, and how does it compare with its own history? BASF India Ltd's P/E is 20.8×, about the lowest it has ever been. Its usual P/E (the middle reading) is 50.5×, over 6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹148.54. Why the multiple is where it is: over the past year earnings per share moved −12.3% while the price moved −33.5%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −1.7% a year; about +23.5% a year came from earnings growth and about −25.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the BASF India business getting better or worse? BASF India Ltd's business is turning around. EPS growth has swung from −42.2% at its low to +62.4%, improving for 2 quarters in a row, with ROCE steady at 14.6%. This is based on 10 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. ## How much does BASF India earn on its capital? BASF India Ltd earned a ROCE of 15% in FY26. Its return on capital used (ROIC) is 4.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 2.8% net margin and 1.77× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 2.8% net margin × 1.77× asset turnover × 2.13× leverage (assets divided by equity) ≈ 10.6% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 16.1% − 12.0% = +4.1 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 16.1% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 13.4%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does BASF India have too much debt? BASF India Ltd has total debt of ₹133 Cr against shareholder equity of ₹3,957 Cr as of Jun 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.05 in FY22 to 0.03 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the BASF India shareholding pattern? No group of BASF India Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved −0.3 points over the same period, to 6.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: +0.7 points over 8 quarters, to 5.2%; Domestic institutions: −0.3 points over 8 quarters, to 6.0%; Promoters: +0.0 points over 8 quarters, to 73.3%. ## How far is BASF India from balance-sheet trouble? For BASF India Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does BASF India rank in its industry? 57.3 out of 100, rank 5 of 20 in Chemicals - Organic, with 71% of the evidence available. BASF India Ltd scores 57.3 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 5. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 23.8 + 11.7 + 14.1 + 7.7 = 57.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is BASF India compared with? BASF India ranks 5 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 57.3 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · quiet · Most evidence points up · 85% evidence 76.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.3/25 · ROCE 27.7% · Operating margin 28% · 100% evidence Valuation 13.2/20 · P/E 12.1× · PEG 0.95 · 100% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 35.5% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 30.4 + 21.3 + 13.2 + 12 = 76.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · losing its lead · Most evidence points up · 81% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 13.3% · Profit 24.2% · Operating margin change 3 points · 88% evidence Capital efficiency 16.8/25 · ROCE 18.9% · Operating margin 14% · 100% evidence Valuation 19.0/20 · P/E 10.6× · PEG 0.32 · 100% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 2.3% · 1 year -10.4% · 25% evidence · 4 of 12 weeks ahead Exact sum: 20.8 + 16.8 + 19 + 9.5 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 78% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 1.5% · Profit 100% · Operating margin change 6 points · 83% evidence Capital efficiency 9.0/25 · ROCE 5.5% · Operating margin 18% · 76% evidence Valuation 10.9/20 · P/E 23.2× · PEG n/a · 50% evidence Relative strength 19.8/20 · Lead over its industry 24.1% · Lead over NIFTY 500 48.6% · 1 year 39.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 21.4 + 9 + 10.9 + 19.8 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) OCCLLTD · breaking out · Too little evidence to rank firmly · 56% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 40.6% · Profit 100% · Operating margin change 7 points · 83% evidence Capital efficiency 12.3/25 · ROCE 13% · Operating margin 28% · 76% evidence Valuation 11.1/20 · P/E 11× · PEG n/a · 15% evidence Relative strength 12.1/20 · Lead over its industry n/a · Lead over NIFTY 500 45.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.6 + 12.3 + 11.1 + 12.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. BASF India Ltd this page BASF · quiet · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 6.5% · Profit 62.4% · Operating margin change 4 points · 88% evidence Capital efficiency 11.7/25 · ROCE 14.5% · Operating margin 10% · 100% evidence Valuation 14.1/20 · P/E 21.4× · PEG n/a · 50% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -13% · 1 year -30.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 23.8 + 11.7 + 14.1 + 7.7 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · leader · Evidence leans up · 67% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.1/25 · ROCE 21.2% · Operating margin 23% · 76% evidence Valuation 6.5/20 · P/E 54.1× · PEG n/a · 50% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 31.9% · 1 year 33.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 20.7 + 18.1 + 6.5 + 11.8 = 57.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · leader · Evidence leans up · 96% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 7.1% · Profit 5.8% · Operating margin change 4 points · 88% evidence Capital efficiency 17.8/25 · ROCE 21.5% · Operating margin 25% · 100% evidence Valuation 15.0/20 · P/E 35.3× · PEG 0.58 · 100% evidence Relative strength 9.9/20 · Lead over its industry -7.6% · Lead over NIFTY 500 12.4% · 1 year 13.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.9 + 17.8 + 15 + 9.9 = 56.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Evidence leans up · 81% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 5.5% · Profit 26% · Operating margin change 7.6 points · 88% evidence Capital efficiency 10.8/25 · ROCE 4.7% · Operating margin 12% · 100% evidence Valuation 13.1/20 · P/E 33.8× · PEG 1.14 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 1.8% · 1 year -22% · 25% evidence · 10 of 12 weeks ahead Exact sum: 21.1 + 10.8 + 13.1 + 9.2 = 54.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 78% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 11.1% · Profit 41.6% · Operating margin change 10 points · 83% evidence Capital efficiency 13.1/25 · ROCE 11% · Operating margin 25% · 76% evidence Valuation 9.1/20 · P/E 28× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry -2.5% · Lead over NIFTY 500 15.2% · 1 year 25.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.2 + 13.1 + 9.1 + 8.2 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) FAIRCHEMOR · quiet · Evidence leans up · 100% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.3/35 · Revenue 17.1% · Profit 100% · Operating margin change 6.2 points · 100% evidence Capital efficiency 7.0/25 · ROCE 3.3% · Operating margin 10% · 100% evidence Valuation 13.0/20 · P/E 32.7× · PEG 0.84 · 100% evidence Relative strength 3.0/20 · Lead over its industry -15.4% · Lead over NIFTY 500 3.2% · 1 year -15.9% · 100% evidence · 9 of 12 weeks ahead Exact sum: 30.3 + 7 + 13 + 3 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. 11. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · breaking out · Evidence leans down · 100% evidence 49.4 out of 100 Growth Capital Valuation Relative
12. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) GFLLIMITED · breaking out · Evidence leans down · 71% evidence 48.6 out of 100 Growth Capital Valuation Relative
13. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · basing · Evidence leans down · 74% evidence 43.7 out of 100 Growth Capital Valuation Relative
14. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) FOSECOIND · leader · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
15. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 85% evidence 40.3 out of 100 Growth Capital Valuation Relative
16. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) OAL · leader · Evidence leans down · 74% evidence 36.5 out of 100 Growth Capital Valuation Relative
17. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) GEMAROMA · quiet · Too little evidence to rank firmly · 51% evidence 32.2 out of 100 Growth Capital Valuation Relative
18. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 58.1 out of 100 Growth Capital Valuation Relative
19. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · leader · Too little evidence to rank firmly · 47% evidence 56.8 out of 100 Growth Capital Valuation Relative
20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to BASF India in size? BASF India is the 2nd largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Fine Organic Industries. Just below it: Elantas Beck India, Balaji Amines, Foseco India, Laxmi Organic Industries and Oriental Aromatics. ### Chemicals - Organic companies close in size

1. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) ₹15,480 crore
2. BASF India Ltd ₹13,198 crore
3. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ₹6,417 crore
4. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) ₹5,721 crore
5. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) ₹4,419 crore
6. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) ₹4,245 crore
7. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) ₹1,916 crore

[All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies)

### Companies close in size in other industries

1. [Maharashtra Scooters Ltd](https://www.sectoralpha.in/stocks/maharashtra-scooters-ltd) ₹13,274 crore · Finance - Holding Company
2. [Punjab & Sind Bank](https://www.sectoralpha.in/stocks/punjab-sind-bank) ₹13,240 crore · Banks - PSU
3. BASF India Ltd ₹13,198 crore
4. [Corona Remedies Ltd](https://www.sectoralpha.in/stocks/corona-remedies-ltd) ₹13,147 crore · Pharma - Formulators
5. [Gujarat Mineral Development Corporation Ltd](https://www.sectoralpha.in/stocks/gujarat-mineral-development-corporation-ltd) ₹13,090 crore · Mining/Minerals

## What else do people ask about BASF India? ### What is BASF India's share price today? BASF India Ltd's share price is ₹2,958.60, −33.5% over the past year. The whole company is worth ₹12,807 Cr on the market. It is at its lowest price of the past 52 weeks (range ₹2,959 to ₹4,449), 20.4% below its 200-day average. The price has been falling for 64 weeks (as of 4 November 2026). ### What were BASF India's latest quarterly results? BASF India Ltd reported revenue of ₹4,824 Cr and net profit of ₹360 Cr for the Jun 2026 quarter. Revenue rose 24.5% and profit rose 162.8% compared with a year earlier. Earnings per share were ₹83.24. The operating margin was 10.0%, 4.0 percentage points higher than a year earlier (as of 4 November 2026). ### What is BASF India's market cap? BASF India Ltd's market capitalisation is ₹12,807 Cr at a share price of ₹2,958.60. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is BASF India performing? BASF India Ltd's share price has been falling for 64 weeks. In its latest quarter, revenue rose 24.5% and profit rose 162.8% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 5 weeks running (as of 4 November 2026). ### Will BASF India's share price go up? This page does not forecast BASF India Ltd's share price. What it shows instead: the share price is ₹2,958.60, and it has been falling for 64 weeks. Its P/E of 20.8× is higher than 0% of its own last 6 years (as of 4 November 2026). ### Who owns BASF India? Promoters own 73.3% of BASF India Ltd, foreign institutions 5.2%, domestic institutions 6.0% and the public 15.6% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 4 November 2026). ### Where is BASF India in its business cycle? BASF India Ltd's FY26 operating margin was 4.4%, against a 9-year range of 3.7% to 13.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 10.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the BASF India story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is BASF India a stock worth studying right now? What the numbers show: BASF India Ltd's share price has fallen more than its earnings. Earnings per share fell 12.3% in a year while the price moved −33.5%. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india
- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india

This is research, not advice. We’re not SEBI-registered.